CClinicalTrials.gg
Sign In
CompletedNCT01807247Updated Feb 4, 2015

Short Effects of a Rehabilitation Session on Gait in Patients With CNS

An observational study in Spastic Gait, Fall Due to Failure of Support and Fatigue, sponsored by Centre d'Investigation Clinique et Technologique 805. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-02-04.

Sponsored by Centre d'Investigation Clinique et Technologique 805 · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the study is to evaluate the short effects of a two rehabilitation session commonly performed in physical therapy,

  1. muscle strengthening of the lower limbs and
  2. effort reconditioning with cyclo ergometer, on gait characteristics (kinematics, kinetics and electromyographic) in patients with central nervous system lesion.
02

Conditions studied

  • Spastic Gait
  • Fall Due to Failure of Support
  • Fatigue

Keywords

  • Strengthening muscle
  • Central nervous system diseases
  • Gait
03

In context

Gait Disorders, Neurologic

327 studies on the registry are indexed under Gait Disorders, Neurologic; 54 are open to participants now.

This study's enrollment of 60 is above the median of 54 across 75 observational studies indexed under Gait Disorders, Neurologic.

Browse Gait Disorders, Neurologic studies →

Lead sponsor

Centre d'Investigation Clinique et Technologique 805 is the lead sponsor of 74 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The population includes patients with various lesions of central nervous system such as post-stroke patients with hemiparesis, patients with spinal cord injury and patients with mutiple sclerosis.

Inclusion criteria

  • Male or female adults aged ≥ 18 years receiving a motor rehabilitation in the service
  • Hemiplegia after stroke or paraplegia incomplete ASIA C or D or multiple sclerosis (EPSS \<5).
  • Walking with or without technical assistance
  • Patients who received and signed information and informed consent
  • Patient who received physiotherapy session for rehabilitation of the lower limbs
  • Patients able to perform the entire study

Exclusion criteria

Exclusion Criteria:

  • Patient with safety measure
  • Pregnant women, breastfeeding
  • Patient who has received botulinum toxin injection of in the lower limbs between 3 weeks and 2 months prior to inclusion in the study
  • Bilateral Brain damage, cerebellar syndrome, apraxia, severe aphasia
  • Orthopedic complications preventing walking
  • Patients who participated in a clinical study within 3 months prior to inclusion • No affiliation to a social security scheme (beneficiary or assignee)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (actual)
Patient registry
No

Groups and cohorts

  • Hemiparetic

    Intensive lower limbs muscles strengthening

    Procedure: Intensive lower limbs muscles strengthening

  • Spinal cord injury

    Intensive lower limbs muscles strengthening

    Procedure: Intensive lower limbs muscles strengthening

  • Multiple sclerosis

    Intensive lower limbs muscles strengthening

    Procedure: Intensive lower limbs muscles strengthening

Interventions

  • ProcedureIntensive lower limbs muscles strengthening
06

What researchers measure

Primary outcomes

  1. Evaluation of functional capacity after rehabilitation session using functional tests such as 6 minutes walking test and timed up and go

    clinical exam, timed up and go, stair test, 6 minutes walking test

    Time frame: 30 min

Secondary outcomes

  1. Evaluation of gait pattern and muscle activation patterns during video and EMG analyzes.

    EMG analysis of rectus femoris, hamstrings, tibialis anterior and soleus

    Time frame: 1 hour

07

Study locations

1 site
  • Hopital Raymond Poincare
    Garches, 92380, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01807247
Lead sponsor
Centre d'Investigation Clinique et Technologique 805
Responsible party
Nicolas ROCHE (MDPHD, Centre d'Investigation Clinique et Technologique 805) — Principal investigator
First posted
Mar 8, 2013
Start date
Feb 2013
Primary completion
Oct 2014
Completion
Oct 2014
Last update
Feb 4, 2015

Study contacts

Nicolas ROCHE, MDPHD
principal investigator · Hôpital RAYMOND POINCARE

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Gait Disorders, Neurologic→

Other studies from this sponsor

Centre d'Investigation Clinique et Technologique 805

Start the discussion